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Abstract 
 
5-Fluorouracil (5-FU) is the first line chemotherapeutic agents for colon cancer 
therapy. Long term used of 5-FU caused cancer cell resistency. Thus, co-chemoteraputics 
agent should be developed to increase cells sensitivty towards 5-FU. Jure leaf  (Nerium 
indicum Mill) extract (JLE) contains oleandrin which has cytotoxic effect on colon cancer cell. 
The ain of this study was to investigated the mechanism of JLE to sensitized colon cancer cell 
toward 5-FU through NF-κB inhibition and MRP protein repression. JLE was extracted by 
soxhletation method. Based on molecular docking to MRP protein, docking score of 
oleandrin (-50,496)  was higher than native ligand ATP (-125,817). Oleandrin could interfere 
interaction with MRP. JLE increased 5-FU sensitivity a dose of 2 µg/mL JLE dan 12.5 µM 5-FU 
with the combination index (CI) of  0.594. Combination of JLE and 5-FU also inhibit p65 
protein expression on WiDr cell. 
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INTRODUCTION 
 
Colon cancer become the third ranking 
of the death cause in the world caused by 
cancer (Li and Lai, 2009). Nowadays, the colon 
cancer wa treated using chemotheraphetical 
agent. The first line chemotherapetical agent for 
colon cancer was 5-Fluorouracil (5-FU). Long 
term use of 5-FU could decreased  cancer cell 
sensitivity toward chemotherapeutics agent.  
MRP is transporter protein which 
involved in eflux process of many 
chemotherapeutics agent. Overexpression of 
MRP in cancer cells cause the lob level of 
chemotherapy efficacy. P-gp was encoded by 
MDR1. NF-κB is transcription factor which 
regulated many gen involved in immunity, 
inflamation, dan cell survival (Ghosh and 
Hayden, 2008). Phosporilation of IκB by IKK 
activated NF-κB and translocated NF-κB in 
nucleus leading to  cell proliferation. The 
inhibition of NF-κB leading to cancer cell 
arrest, cells dead, increasing sensitvityf to 
chemotherapeutics agent (Escárcega, et al., 
2007). MDR1 was activated trough NF-κB 
pathway (Thévenod, et al., 2000; Kuo, et al., 
2002). 
Jure leaf (Nerium indicum Mill.) 
contains oleandrin, a glicosyde that has 
cytotoxic activity toward cancer cell (Newman, 
et al., 2007). The aims of this study was to 
investigate the potency of jure leaf extract 
(JLE) as co-chemotherapetical agent toward 5-
FU resistency in colon cancer. The mechanism 
was investigated by molecular docking between 
oleandrin and MRP. Cell viability observation 
was conducted by MTT assay. The inhibition of 
protein expression was conducted by 
immunofluorescence assay. 
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MATERIAL AND METHOD  
 
Plant Collection and Extraction 
Jure leaf (Nerium indicum Mill.) was 
obtained from Yogyakarta and identified by 
Pharmaceutical Biology Department of Faculty 
of Pharmacy. Universitas Gadjah Mada. Jure 
leaf was extracted by soxhletation method using 
96% ethanol and evaporated using Rotary 
evaporator. Identification of phytochemical 
coumpound of the extract was conducted by 
thin layer chromatography (TLC) with silica gel 
60GF 254 as stationery phase and 
chloroform:aceton (8:2) the mobile phase of. 
The TLC    visualization was conducted using  
p-anisaldehyde and   AlCl3  as the sprayer 
reagent, then was observed in UV 366 nm. 
 
Cell Culture 
 WiDr colon cancer cell cells were 
obtained from Prof.  Masashi Kawaichi (Nara 
Institute of Science and Technology, NAIST, 
Japan). Cells were cultured at 37
o
C with a 
humidified incubator, 5% CO2, in suitable 
medium RPMI 1640 (Gibco) supplemented 
with 10% Fetal Bovine Serum (FBS) (Sigma), 
10,000 UI/mL penicillin-streptomycin (Gibco). 
 
Cytotoxic Assay 
Cytotoxicity of WiDr cells were 
determined using MTT assay (Mosmann, 1983) 
with minor modification. Cells were distributed 
into 96-well, then incubated in 37˚C incubator 
supplemented with 5% CO2. After 24 hours 
incubation, culture medium was removed, 
followed by treatment using JLE and 5-FU. 
Next day, 0.5 mg/mL of MTT (3-[4,5-dimethyl 
thiazole-2-yl(-2,5- diphenyltetrazolium-
bromide)]) in PBS was added, followed by 4 
hours incubation in 37˚C with 5% CO2. After 
that 10%
v
/v SDS in HCl 0.01N as stopper 
reagent was then added. Plate was then kept 
with protection from light overnight, continued 
with absorbance determination (λ 595 nm) 
using ELISA reader (Bio-Rad). 
 
 
 
Immunofluorescence Assay 
Cells were grown on coverslip in 24-well 
plate up to 80% confluent. Cell were treated 
with compounds, single and combination with 
chemotherapeutic agents and incubated for 24 
hours. After 24 hours, cell were fixed by 70% 
ethanol and incubated for 15 min at room 
temperature. After rinsed with PBS, cells were 
incubated with blocking serum 1% BSA for 30 
min at room temperature. Then, cells were 
incubated with primary antibody (p65) for 1 
hour at room temperature. After rinsed with 
PBS, cells were incubated with secondary 
antibody conjugated by FITC for 1 hour at 
room temperature in the dark. Then, cell were 
added by DAPI solution and incubated for 10 
min at room temperature in the dark. After 
rinsed with PBS, cell were added with 
mounting solution (Fluoromount), put on slide 
glass, and store at 4°C. The protein expressions 
were observed under fluorescence microscope. 
 
Molecular Docking 
Molecular docking was conducted using 
PLANTS software. Protein target file (2CBZ) 
was operated using YASARA software to 
arrange the environment condition which is 
appropriate with human physiology. Oleandrin 
structure was build up using Marvin Sketch 
software. The docking process was conducted 
then. 
In vitro test consist of media making, 
cell culture, cytotoxic test, and 
immunofluorescence   test. This method is 
conducted in Parasitology laboratorium, 
Faculty of Medicine, Gadjah Mada University.  
 
RESULT AND DISCUSSION 
 
Jure Leaf Extract (JLE) Extraction and 
Identification 
Jure leak extraction was conducted by 
soxhletation method using 96% ethanol and 
obtained extract with the rendement of 82.44% 
b/v. the TLC profile showed that there was a 
blue fluorescence that showed cardenolyde 
steroid group in JLE (Fig. 1). 
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Figure 1. Heart glicosyde test (oleandrin) on (a) visible ray (b) UV 254 and (c) UV 36
Molecular Docking Result of Oleandrin 
and MRP Protein 
Molecular docking was conducted by 
PLANTS software. The protein PDB ode is 
2CBZ. The experimental ligand is ATP. The 
test compound is oleandrin. Based on molecular 
docking  on  MRP  protein  result,  the  docking 
score of oleandrin (-50.496) is higher than 
native ligand ATP (-125.817) (Table 1). This 
result is strengthen by the molecular docking 
visualization using MOE that showed the 
similar binding site on some amino acid 
residues  of  native  ligand   and  oleandrin  
(Fig. 2). 
 
 
 
Table 1. Docking Score 
 
 
 
 
 
 
 
 
 
 
 
 
                                     
 
  
 
 
Figure 2. Docking Visualization (a) 2D (b) 3D 
 
 
 
 
 
 
 
(a) 
 
(b) 
 
(c) 
Docking Score of MRP 
 
2CBZ 
RMSD 0.8822 
Oleandrin -50.496 
Ligan native -125.817 
(a) 
 
(b) 
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The Cytotoxic Test Result of JLE on 
WiDr Colon Cancer Cell 
  The cytotoxic test on WiDr cell was 
conducted using MTT assay. C50 of JLE was 
4µg/mL, and IC50 5-FU is 100µM. JLE has 
potent cytotoxic activity on WiDr cell. Based 
on combination test, JLE increased 5-FU 
sensitivity with the optimum dose of 2 µg/mL 
JLE and 12,5 µM 5-FU with the CI score of 
0,594. Based on CI score, it could be concluded 
that combination of JLE and 5-FU had 
synergist effect (Fig. 3). 
The p65 Protein Expression by 
Immunofluorescence Assay  
The p65 protein expression on WiDr was 
detected by immunofluorescence assay. The 
immunofluorescence result showed that JLE 
inhibited p65 protein expression at the optimum 
dose of JLE and 5-FU (Fig. 4). 
This study can give an alternatif therapy 
which is more effective and targetted in the 
inhibition  of  colon  cancer  cell  proliferation, 
and solved 5-FU resistency in colon cancer 
therapy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cell viability of WiDr after treated with JLE (a) and 5-FU (b) for 48h. cytotoxic assay 
was performed using MTT assay. Cells viability of combination of JLE and 5-FU (c). 
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Figure 4. p65 protein expression on WiDr cell observed by immunofluorescence assay 
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